from actually kind of influencing that debate, it has kidnapped the debate and put it into another unhelpful direction. but debate and put it into another unhelpful direction. debate and put it into another unhelpful direction. but do you think that the unhelpful direction. but do you think that the issue unhelpful direction. but do you think that the issue around i unhelpful direction. but do you i think that the issue around richard sharp, the bbc chair, has made it harderfor the bbc to sharp, the bbc chair, has made it harder for the bbc to defend what is going on? would it be better, in your view, going on? would it be better, in yourview, if going on? would it be better, in your view, if the board said to its chair, which they would have the power to do, not tim davie alone, but the board could say or he could decide to step aside for a while while the inquiry into his links to borisjohnson is concluded? abmd while the inquiry into his links to boris johnson is concluded? and
Robeco Institutional Asset Management B.V. grew its holdings in Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 20.3% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 14,739 shares of the medical equipment provider’s stock after buying an additional 2,488 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Abiomed were worth […]
Shares of Abiomed, Inc. (NASDAQ:ABMD – Get Rating) reached a new 52-week high during trading on Tuesday . The stock traded as high as $383.59 and last traded at $379.72, with a volume of 51256 shares traded. The stock had previously closed at $252.08. Analysts Set New Price Targets Several research firms have recently commented […]
Victory Capital Management Inc. cut its holdings in shares of Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 1.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,175 shares of the medical equipment provider’s stock after selling 328 shares during the quarter. Victory […]
Bank of Montreal Can reduced its stake in Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 12.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,119 shares of the medical equipment provider’s stock after selling 7,148 shares during the quarter. Bank […]